Redhill Biopharma
RDHL
#10477
Rank
โ‚ฌ3.4 M
Marketcap
1,02ย โ‚ฌ
Share price
-0.83%
Change (1 day)
-85.54%
Change (1 year)

Revenue for Redhill Biopharma (RDHL)

Revenue in 2022: โ‚ฌ57.61 Million

According to Redhill Biopharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ30.7 Million. In 2022 the company made a revenue of โ‚ฌ57.61 Million a decrease over the revenue in the year 2021 that were of โ‚ฌ75.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Redhill Biopharma from 2012 to 2022

Annual revenue

Year Revenue Change
2022โ‚ฌ57.61 M-23.92%
2021โ‚ฌ75.72 M44.72%
2020โ‚ฌ52.32 M831.74%
2019โ‚ฌ5.61 M-23.15%
2018โ‚ฌ7.3 M118.82%
2017โ‚ฌ3.33 M3377.95%
2016โ‚ฌ0.09 M3399.65%
2015โ‚ฌ0 M-99.95%
2014โ‚ฌ5.76 M66270.22%
2013โ‚ฌ0 M-28.16%
2012โ‚ฌ0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sanofi
SNY
โ‚ฌ40.82 B 132,855.88%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ55.17 B 179,603.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.38 B 118,385.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
โ‚ฌ0.52 B 1,608.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.41 B 46,832.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel